Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

stacey

Stacey Coen appointed Senior Vice President and Chief Business Officer at ImmunoGen

June 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunoGen have appointed Stacey Coen as their new Senior Vice President and Chief Business Officer. She joins the company from …
Appointment
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

June 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …
News
novartis_outside_1

Novartis’ Cosentyx hits primary goal in Phase 3 non-radiographic axial spondyloarthritis study

June 4, 2020 Research and Development Cosentyx, Novartis, axial spondyloarthritis

New Phase 3 data has been released on the efficacy of Novartis’ interleukin (IL)-17A inhibitor Cosentyx (secukinumab), showing that the …
News
janssen_latest_logo_on_sign_closer

Janssen’s Tremfya shows skin clearance benefit for psoriatic arthritis patients in two Phase 3 studies

June 4, 2020 Research and Development Janssen, Tremfya, psoriatic arthritis

Janssen has revealed data from two Phase 3 trials for Tremfya (guselkumab), showing improvement in skin clearance and symptoms in …
News
remdesivir_ulrich_perrey

India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020 Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …
News
chloroquine

Lancet expresses concern over published hydroxychloroquine and chloroquine paper

June 3, 2020 Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine

The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …
News
fda

The Association of American Physicians & Surgeons sue FDA to end restrictions on hydroxychloroquine, despite evidence it can be life threatening

June 3, 2020 Research and Development AAPS, COVID-19, coronaviryus

The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access …
News
ibuprofen

Kings College London launches trial investigating the effectiveness of ibuprofen in COVID-19 patients

June 3, 2020 Research and Development COVID-19, coronavirus, ibuprofen

Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 3, 2020 Research and Development COVID-19, coronavirus

COVID-19 treatments dominate the news this week as Russia is set to start its roll out of the anti-viral drug …
News
david_paul_morrisbloomberg

Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows

June 2, 2020 Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …
News
ipsen

Ipsen appoints David Loew as new Chief Executive Officer

June 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

David Loew will leave his position as the head of Sanofi’s vaccine division to become the Chief Executive Officer of …
Appointment

How Big Brother is helping to fight COVID-19

June 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, NHS, coronavirus, feeature, pharma, track and trace

Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …
Feature
putey

Russia to begin administering anti-viral COVID-19 drug next week

June 1, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Russia, coronavirus, pandemic, virus

Russia will start its roll out of the anti-viral drug Avifavir (favipiravir) to COVID-19 patients next week, according to the …
News
gilead-sciences

Gilead’s magrolimab shows promising responses in untreated myelodysplastic syndrome and acute myeloid leukaemia at ASCO 2020

June 1, 2020 Research and Development, Sales and Marketing ASCO 2020, Cancer, Gilead, leukaemia, magrolimab

Gilead took the opportunity at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to unveil new Phase 1b …
News
shutterstock_243110086

First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment

May 29, 2020 Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir

The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026